Skip to content

Avni Chandrakant Shah, MD

NPI 1699938928ActiveIndividual· Pediatrics, Pediatric Endocrinology· San Francisco, CA

Pediatrics, Pediatric Endocrinology (MD) in San Francisco, California, licensed in CA, with an NPI issued in July 2008. Novo Nordisk Inc reported $16.67 in payments in 2025, mostly food and beverage.

Overview

NPI1699938928
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 7, 2008
Last updated in NPPESMar 17, 2018

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Endocrinology Primary2080P0205XA83856CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$16.67 · 1 payment from 1 company
  • 2024$39.54 · 2 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$16.671

What the 2025 payments were for

  • Food and Beverage$16.67 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Endocrinology providers in San Francisco

All 19 Pediatrics, Pediatric Endocrinology providers in San Francisco · All Pediatrics, Pediatric Endocrinology providers in California